Rating Action: Moody's downgrades Diplomat Pharmacy to Caa1; developing outlook. Global Credit Research- 12 Nov 2019. New York, November 12, 2019-- Moody's Investors Service downgraded the ratings of Diplomat Pharmacy, Inc. including the Corporate Family Rating to Caa1 from B3, the Probability of Default Rating to Caa1-PD from B3-PD, the senior secured rating to Caa1 from B3 and the Speculative Grade Liquidity Rating to SGL-4 from SGL-3.
Rating Action: Moody's downgrades Diplomat Pharmacy to B3; outlook developing. Global Credit Research- 09 Aug 2019. New York, August 09, 2019-- Moody's Investors Service downgraded the ratings of Diplomat Pharmacy, Inc. including the Corporate Family Rating to B3 from B2, the Probability of Default Rating to B3-PD from B2-PD, and the senior secured rating to B3 from B2.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Diplomat Pharmacy, Inc.. Global Credit Research- 23 May 2019. New York, May 23, 2019-- Moody's Investors Service has completed a periodic review of the ratings of Diplomat Pharmacy, Inc. and other ratings that are associated with the same analytical unit.
Rating Action: Moody's downgrades Diplomat Pharmacy's CFR to B2; negative outlook. Global Credit Research- 27 Feb 2019. New York, February 27, 2019-- Moody's Investors Service downgraded the ratings of Diplomat Pharmacy, Inc. including the Corporate Family Rating to B2 from B1, the Probability of Default Rating to B2-PD from B1-PD, the senior secured rating to B2 from B1, and the Speculative Grade Liquidity Rating to SGL-3 from SGL-2.
A director at Diplomat Pharmacy Inc sold 90,633 shares at 18.578USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
NEW ORLEANS--(BUSINESS WIRE)-- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Diplomat Pharmacy, Inc. (NYSE: DPLO). On November 2, 2016, the Company announced disappointing results for the third quarter of 2016 including earnings per share of $0.21 on revenues of $1.18 billion and lowered high end guidance for 2016 which it attributed to “softness in the hepatitis C business” and its handling ...
WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violation claims and breach of fiduciary duty claims against Diplomat Pharmacy, Inc. (NYSE: DPLO) (“Diplomat Pharmacy” or the “Company”). If you currently own shares of Diplomat Pharmacy and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-in...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Diplomat Pharmacy, Inc. (“Diplomat Pharmacy”) (NYSE: DPLO) between October 9, 2014 and November 2, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Eastern District of Michigan. To get more information go to: http://www.zlk.com/pslra/diplomat-pharmacy or contact Joseph E. Le...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Michigan on behalf of investors who purchased Diplomat Pharmacy, Inc. (NYSE:DPLO) securities between October 9, 2014 and November 2, 2016. Click here to learn about the case: http://www.wongesq.com/pslra/diplomat-pharmacy. There is no cost or obligation to you. According to the complaint, during the Class Period, Diplomat Pharmacy issued false and misleading state...
OKLAHOMA CITY--(BUSINESS WIRE)-- On November 20, 2016, a class action lawsuit was filed in the United States District Court for the Eastern District of Michigan against Diplomat Pharmacy, Inc. (NYSE: DPLO). Federman & Sherwood reminds current and former shareholders of Diplomat Pharmacy, Inc. that they only have until Monday, January 9, 2017 to move the court for appointment as a lead plaintiff in this case. The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated t...
Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Diplomat Pharmacy, Inc. (“Diplomat Pharmacy”) (NYSE:DPLO) between October 9, 2014 and November 2, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Eastern District of Michigan. To get more information go to: http://www.zlk.com/pslra/diplomat-pharmacy or contact Joseph E. Lev...
BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) securities between October 9, 2014 and November 2, 2016, inclusive (the “Class Period”). Diplomat investors have until January 9, 2017 to file a lead plaintiff motion. Investors suffering losses on their Diplomat investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Michigan on behalf of investors who purchased Diplomat Pharmacy, Inc. (NYSE:DPLO) securities between October 9, 2014 and November 2, 2016. Click here to learn about the case: http://www.wongesq.com/pslra/diplomat-pharmacy. There is no cost or obligation to you. According to the complaint, during the Class Period, Diplomat Pharmacy issued false and misleading state...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.